Effect of Strong P-gp and BCRP Inhibition, Using Cyclosporine and Quinidine as Probes, on the Pharmacokinetics of Oral Rimegepant 75 mg in Healthy Subjects (P2-2.001)
Bertz R, Anderson M, Collins J, Stringfellow J, Madonia J, Bharwaj R, Finley J, Stock D, Coric V, Croop R. Effect of Strong P-gp and BCRP Inhibition, Using Cyclosporine and Quinidine as Probes, on the Pharmacokinetics of Oral Rimegepant 75 mg in Healthy Subjects (P2-2.001). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.877.Peer-Reviewed Original Research